- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Carlsmed Inc (CARL)
The Carlsmed share price today is 12.59, view NASDAQ CARL stock exchange data. Track the latest Carlsmed share price with real-time updates on CARL stock performance including market cap, day range, 52-week range and dividend yield. Access CARL charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.31
12.87
52 wk Range
8.50
17.19
CARL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.3112.87
52 wk Range
8.5017.19
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CARL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
18.60
Upside
+47.74%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Carlsmed receives Investment Bank Analyst Rating Update- Investing.com
Pro
Form 4 Carlsmed Inc For: 22 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.60
(+47.74% Upside)
Carlsmed Inc Earnings Call Summary for Q1/2026
- Carlsmed Q1 2026 revenue surged 58% YoY to $16.1M; gross margin improved 220 bps to 77.1% driven by surgeon adoption growth
- Net loss widened to $8.7M from $5.7M as operating expenses jumped 62% to $21.7M, pressuring profitability despite revenue gains
- Stock declined 2.31% to $9.09 in aftermarket trading, near 52-week low of $8.50; shares down 26% YTD amid investor expense concerns
- Company maintains strong balance sheet with $97.1M cash; bilateral lumbar fusion platform launch scheduled for Q4 2026
- Management projects continued revenue growth and improved adjusted EBITDA, targeting profitability through personalized surgery platform expansion
Last Updated: 06-05-2026, 02:50 am
Read Full TranscriptEarnings
Latest Release
05-05-2026
EPS / Forecast
-0.32 / -0.37
Revenue / Forecast
16.1M / --
Compare CARL to Peers and Sector
Metrics to compare | CARL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCARLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.5x | −2.7x | −0.4x | |
PEG Ratio | −0.14 | −0.31 | 0.00 | |
Price/Book | 3.7x | 4.7x | 2.6x | |
Price / LTM Sales | 6.1x | 3.1x | 3.0x | |
Upside (Analyst Target) | 43.0% | 61.0% | 56.0% | |
Fair Value Upside | Unlock | 5.5% | 9.1% | Unlock |
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Carlsmed (CARL) Share Price Today?
The Carlsmed share price today is 12.59.
What is the current Carlsmed (CARL) share price and day range?
As of 03-08-2026, the Carlsmed share price is 12.59, with a previous close of 12.59. The share price has ranged from 12.31 to 12.87 today, while the 52-week range spans from 8.50 to 17.19.
What Is the Carlsmed Market Cap?
As of today, Carlsmed market cap is 342.26M.
What Is the Carlsmed (CARL) Share Price Target?
The average 12-month share price target for Carlsmed is 18.60, with a high estimate of 23 and a low estimate of 17. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +47.74% Upside potential.
What Is Carlsmed's Earnings Per Share (TTM)?
The Carlsmed EPS (TTM) is -1.64.
When Is the Next Carlsmed Earnings Date?
Carlsmed will release its next earnings report on 05-08-2026.
From a Technical Analysis Perspective, Is CARL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Carlsmed Trade On?
Carlsmed is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Carlsmed?
The stock symbol for Carlsmed is "CARL."
How Many Times Has Carlsmed Stock Split?
Carlsmed has split 0 times.
How Many Employees Does Carlsmed Have?
Carlsmed has 127 employees.
What Is the CARL Premarket Price?
CARL's last pre-market stock price is 12.68. The pre-market share volume is 5,020.00, and the stock has changed by 0.09, or 0.71%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.